China’s biotech industry has seen tremendous growth in recent years, with companies like Bloomage Biotech and Sinopharm leading the way in transforming healthcare. At the China International Consumer Products Expo (CICPE) held in south China's Hainan Province, companies showcased their latest products and technologies, demonstrating how they are advancing the field of biotech and improving patient outcomes.
Bloomage Biotech set up booth at the China International Consumer Products Expo in Haikou City of south China's Hainan Province, April 10, 2023. /Bloomage Biotech
Bloomage Biotech set up booth at the China International Consumer Products Expo in Haikou City of south China's Hainan Province, April 10, 2023. /Bloomage Biotech
Bloomage Biotech set up booth at the China International Consumer Products Expo in Haikou City of south China's Hainan Province, April 10, 2023. /Bloomage Biotech
Bloomage Biotech set up booth at the China International Consumer Products Expo in Haikou City of south China's Hainan Province, April 10, 2023. /Bloomage Biotech
Bloomage Biotech, known for its expertise in synthetic biology, particularly for producing hyaluronic acid, presented a range of biomaterials and biopharmaceuticals at the expo.
The company owns a set of homegrown key technologies in producing hyaluronic acid through microbial fermentation, which not only improves product quality but also significantly increases productivity and reduces production costs.
Products of Bloomage Biotech's hyaluronic acid cosmeceutical product are displayed at the expo, April 15, 2023. /CGTN
Products of Bloomage Biotech's hyaluronic acid cosmeceutical product are displayed at the expo, April 15, 2023. /CGTN
Samples of Bloomage Biotech stem cell culture medium are displayed at the expo, April 15, 2023. /CGTN
Samples of Bloomage Biotech stem cell culture medium are displayed at the expo, April 15, 2023. /CGTN
On April 11, Bloomage Biotech revealed its industry park in Haikou which includes a production line for stem cell culture medium. The line was a result of the company's strategic cooperation with Japan's Rohto Pharmaceutical and BioMimetics Sympathies thanks to Hainan's free trade port policies.
The localized product is expected to be launched in the second half of this year, the company said.
Meanwhile, China's COVID-19 vaccine producer Sinopharm showcased its expansion into the wellness industry. With about 100 units of product displayed at the expo, the company intend to tap into the blooming wellness market.
Logo of Sinopharm Group is seen at the company booth at the expo, April 15, 2023. /CGTN
Logo of Sinopharm Group is seen at the company booth at the expo, April 15, 2023. /CGTN
Wellness products of Sinopharm Group are displayed at the expo, April 11, 2023. /CGTN
Wellness products of Sinopharm Group are displayed at the expo, April 11, 2023. /CGTN
Sinopharm also launched its domestically developed inactivated rabies vaccine that intends to break the monopoly of foreign brands in the sector in the Chinese market.
Sinopharm launched its domestically produced pet health products on April 12, 2023. /Sinopharm Group
Sinopharm launched its domestically produced pet health products on April 12, 2023. /Sinopharm Group
Samples of Sinopharm domestically developed inactivated rabies vaccine are seen at the expo, April 15, 2023. /CGTN
Samples of Sinopharm domestically developed inactivated rabies vaccine are seen at the expo, April 15, 2023. /CGTN